Matching trials
1,853 results
- POINTIndependent statistical analysis of Pediatric Oncology Nutrition Intervention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06175273).
- POINTIndependent statistical analysis of Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- POLARIXIndependent statistical analysis of the POLARIX phase 3 trial evaluating polatuzumab vedotin with R-CHP versus R-CHOP in diffuse large B-cell lymphoma, including trial design, endpoints, statistical methodology, and interpretation.
- PORTEC-2An independent statistical analysis of PORTEC-2, a randomized phase 3 trial comparing external-beam radiation therapy with vaginal brachytherapy after surgery for stage I endometrial cancer.
- Portion Control Treatment for Obesity: Complete Statistical AnalysisIndependent statistical analysis of Portion Control Treatment for Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01451554).
- Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels: Complete Statistical AnalysisIndependent statistical analysis of Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- POSTOPIndependent statistical analysis of Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01377467).
- PPOWERIndependent statistical analysis of Pragmatic Prehospital Group O Whole Blood Early Resuscitation Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03477006).
- Pramipexole Conversion to Ropinirole Controlled Release (CR): Complete Statistical AnalysisIndependent statistical analysis of Pramipexole Conversion to Ropinirole Controlled Release (CR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00275275).
- PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD: Complete Statistical AnalysisIndependent statistical analysis of PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRE-SURGE1Independent statistical analysis of PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00829829).
- Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody: Complete Statistical AnalysisIndependent statistical analysis of Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRECISIONAn independent statistical analysis of the phase 3 PRECISION trial evaluating MRI-targeted biopsy and TRUS-biopsy for clinically significant prostate neoplasm.
- PreFaiRIndependent statistical analysis of Comparative Effectiveness of Pregnancy Failure Management Regimens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02012491).
- PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin: Complete Statistical AnalysisIndependent statistical analysis of PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PREMIERIndependent statistical analysis of Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Preoperative Acetaminophen and Carbohydrate Loading: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Acetaminophen and Carbohydrate Loading: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03131713).
- PREPAREIndependent statistical analysis of PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03070223).
- PRESERVEIndependent statistical analysis of the randomized phase 3 PRESERVE trial evaluating intravenous sodium bicarbonate versus saline and oral N-acetylcysteine versus placebo for serious patient-centered events following angiography.
- PRESERVEIndependent statistical analysis of Prevention of Serious Adverse Events Following Angiography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01467466).
- PRESIDEIndependent statistical analysis of A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking…
- PREVENT-HDA detailed statistical analysis of the phase 3 PREVENT-HD trial of rivaroxaban versus placebo in medically ill outpatients with acute symptomatic COVID-19 infection, including its time-to-event endpoints, hazard ratio, confidence interval, log-rank…
- PREVENT-HDIndependent statistical analysis of A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019…
- Preventing and Arresting Dental Root Surface Caries in Community-dwelling Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Preventing and Arresting Dental Root Surface Caries in Community-dwelling Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Preventing Sexual Transmission of HIV With Anti-HIV Drugs: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sexual Transmission of HIV With Anti-HIV Drugs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00074581).
- Prevention of Adult Caries Study (PACS): Complete Statistical AnalysisIndependent statistical analysis of Prevention of Adult Caries Study (PACS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00357877).
- Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS): Complete Statistical AnalysisIndependent statistical analysis of Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01171794).
- Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): Complete Statistical AnalysisIndependent statistical analysis of Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00602420).
- Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients: Complete Statistical AnalysisIndependent statistical analysis of Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRIDEIndependent statistical analysis of A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.: Complete Statistical AnalysisIndependent statistical analysis of Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.: primary endpoint results,…
- Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™: Complete Statistical AnalysisIndependent statistical analysis of Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PRIMEIndependent statistical analysis of the PRIME phase 3 trial of panitumumab plus FOLFOX versus FOLFOX alone in metastatic colorectal cancer, including progression-free survival, overall survival, objective response, and statistical methodology.
- PRIMEIndependent statistical analysis of Pain Reduction With Intranasal Medications for Extremity Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02778880).
- PRINTOJDMTRIndependent statistical analysis of Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00323960).
- PRISMIndependent statistical analysis of Efficacy and Safety Study of I10E in Treatment of Patients With CIDP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRISMSIndependent statistical analysis of the PRISMS phase 3 trial of alteplase in participants with mild stroke, covering the Day 90 modified Rankin Scale endpoint, risk difference, odds ratios, safety outcomes, trial design,…
- PRKIndependent statistical analysis of Comparison of Cross-cylinder and Conventional Photorefractive Keratectomy(PRK) in Correcting Medium-high Astigmatism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRO 140 in Treatment-Experienced HIV-1 Subjects: Complete Statistical AnalysisIndependent statistical analysis of PRO 140 in Treatment-Experienced HIV-1 Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03902522).
- PROCLAIMIndependent statistical analysis of the PROCLAIM phase 3 trial, including its randomized design, overall survival analysis, progression-free survival, response, relapse patterns, swallowing outcomes, safety, statistical methods, and interpretation.
- PRODIGE 23Independent statistical analysis of PRODIGE 23, a phase 3 randomized trial evaluating neoadjuvant mFolfirinox in patients with resectable locally advanced rectal cancer.
- PRODIGE 24Independent statistical analysis of PRODIGE 24, a phase 3 randomized trial comparing adjuvant mFOLFIRINOX with gemcitabine in resected pancreatic adenocarcinoma.
- ProFEIBAIndependent statistical analysis of Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PROFILE 1014Independent statistical analysis of PROFILE 1014, evaluating crizotinib versus pemetrexed plus cisplatin or carboplatin in ALK-positive non-squamous lung cancer, with detailed interpretation of progression-free survival, overall survival, response, patient-reported outcomes, and statistical…
- PROGIndependent statistical analysis of Progesterone Treatment for Cocaine-dependent Women: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00632099).
- PrometheusIndependent statistical analysis of Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PROMINENTIndependent statistical analysis of Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PROMIS-IIAn independent statistical analysis of PROMIS-II, a phase 3 placebo-controlled trial of colistimethate sodium in non-cystic fibrosis bronchiectasis, explaining the negative binomial analysis of the annual pulmonary exacerbation rate and its rate…
- PROMISE-2Independent statistical analysis of the PROMISE-2 phase 3 trial of ALD403 (eptinezumab) for the prevention of chronic migraine, including trial design, endpoints, ANCOVA, MMRM, Cochran-Mantel-Haenszel analyses, reported results, safety, and statistical interpretation.
- PROMOTE-PIsIndependent statistical analysis of Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00993031).